Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Cy3 NHS Ester: Advanced Protein & Organelle Labeling Work...

    2026-03-17

    Cy3 NHS Ester (Non-Sulfonated): Empowering Advanced Protein and Organelle Labeling Workflows

    Principle and Setup: The Foundation of Sensitive Biomolecule Labeling

    Cy3 NHS ester (non-sulfonated) is a member of the cyanine dye family, engineered for fluorescent dye for amino group labeling in diverse biomolecules, including soluble proteins, peptides, and oligonucleotides. With excitation and emission maxima at 555 nm and 570 nm, respectively, it emits a bright orange fluorescence, ideally suited for multiplexed detection using standard TRITC filter sets. Its high molar extinction coefficient (150,000 M⁻¹cm⁻¹) and quantum yield (0.31) underpin the dye’s sensitivity, facilitating the detection of low-abundance targets in complex biological samples.

    Unlike water-soluble analogs, Cy3 NHS ester (non-sulfonated) from APExBIO requires dissolution in organic solvents such as DMSO or DMF (≥59 mg/mL in DMSO; ≥25.3 mg/mL in ethanol with sonication). This property ensures robust conjugation with primary amines under precisely controlled conditions, making it indispensable for high-precision biomedical imaging and protein labeling with Cy3. The dye’s solid-state stability (up to 24 months at -20°C, protected from light) and room temperature transport resilience (up to 3 weeks) further streamline experimental logistics.

    Protocol Excellence: Stepwise Labeling and Workflow Optimization

    1. Preparation of Dye and Biomolecule

    • Dye Stock Solution: Dissolve Cy3 NHS ester (non-sulfonated) in anhydrous DMSO to a concentration of 10 mM. Protect from light and use within 24 hours to ensure reactivity.
    • Biomolecule Buffer Exchange: Desalt and buffer-exchange proteins, peptides, or oligonucleotides into bicarbonate buffer (pH 8.3) to maximize amine availability and reactivity. Avoid amine-containing buffers (e.g., Tris, glycine).

    2. Conjugation Reaction

    • Reaction Setup: Add dye solution dropwise to biomolecule (molar ratio: typically 3–10 equivalents of dye per biomolecule, depending on labeling density required).
    • Incubation: React at room temperature for 1 hour in the dark, gently agitating the mixture.
    • Quenching: Add 1 M Tris-HCl (pH 7.5) to a final concentration of 50 mM to quench unreacted NHS ester.

    3. Purification and Validation

    • Purge Free Dye: Remove unconjugated dye via gel filtration (e.g., Sephadex G-25), ultrafiltration, or HPLC.
    • Quantification: Measure absorbance at 555 nm and use extinction coefficient for precise degree-of-labeling (DOL) calculations.
    • Functionality Check: For functional studies (e.g., organelle targeting), validate that labeling does not impair biomolecule activity.

    For a comprehensive, scenario-driven walkthrough, Scenario-Driven Solutions with Cy3 NHS Ester (Non-Sulfonated) offers detailed tips for cell-based and in vitro applications, complementing this protocol.

    Advanced Applications: From Autophagy Research to Multiplexed Imaging

    Enabling Organelle-Targeted Degradation Research

    The versatility of Cy3 NHS ester (non-sulfonated) shines in next-generation research platforms such as NanoTACOrg, as highlighted in the reference study Modular Nanoassemblies Mimicking p62 Aggregates for Targeted Organelle Sequestration and Degradation against Breast Cancer. In this context, Cy3-labeled proteins or peptides can be incorporated into nanoparticle assemblies to track dynamic interactions during selective autophagy, organelle clustering, and metabolic pathway reprogramming.

    • Multiplexed Organelle Visualization: Cy3’s distinct excitation/emission profile (orange fluorescent dye excitation 555 nm emission 570 nm) allows simultaneous imaging alongside other fluorophores, facilitating multi-organelle tracking in live or fixed cell systems.
    • Quantitative Trafficking: High quantum yield and extinction coefficient provide single-molecule sensitivity, supporting robust quantification of cargo sequestration, organelle degradation, and autophagosome recruitment.
    • Integration with Advanced Platforms: The dye’s compatibility with TRITC channels ensures seamless imaging with common fluorescence microscopes, confocal systems, and high-content imagers.

    For an in-depth discussion on Cy3’s role in autophagy and metabolic labeling workflows, see Expanding Horizons in Organelle-Targeted Research, which extends the applications into metabolic and signaling pathway mapping.

    Comparative Advantages Versus Sulfo-Analogues

    • Labeling Efficiency: Non-sulfonated Cy3 NHS ester achieves higher labeling densities in organic co-solvent systems, making it ideal for robust, scale-sensitive applications such as bulk protein or nanoparticle labeling.
    • Experimental Flexibility: Though sulfo-Cy3 NHS esters are water-soluble and gentler for delicate proteins, the non-sulfonated form delivers superior performance in workflows where organic solvents are compatible—such as nanoparticle conjugation, peptide labeling, and oligonucleotide modification.
    • Data-Driven Insight: Published studies report that Cy3 NHS ester-labeled conjugates exhibit signal-to-noise ratios up to 5-fold higher than some legacy rhodamine dyes under identical imaging conditions (see Atomic Facts for Protein & Oligonucleotide Imaging for benchmarking data).

    Troubleshooting and Optimization: Ensuring Consistency and Performance

    • Dye Solubility: If dissolution is sluggish, use ultrasonication and anhydrous solvents. Avoid water; Cy3 NHS ester is insoluble and will hydrolyze, reducing labeling efficiency.
    • Buffer Interference: Remove or avoid primary amine-containing buffers before labeling; these compete for Cy3 NHS ester and drastically reduce conjugation yield.
    • Over-Labeling: Excessive dye can quench fluorescence or impair biomolecule function. Titrate dye:biomolecule ratios and verify functional retention via biochemical assays or activity screens.
    • Storage Conditions: Store dry dye at -20°C, protected from light. Do not store dye solutions for extended periods—hydrolysis of the NHS ester can occur within hours in solution.
    • Degree of Labeling (DOL): Quantify labeling via absorbance at 555 nm, using the provided extinction coefficient. DOL outside the optimal range (usually 1–3 dyes per protein) may indicate incomplete reaction or over-labeling.
    • Photobleaching: During imaging, minimize exposure to intense light. Employ antifade reagents or imaging protocols that limit photodamage to preserve signal intensity.

    For atomic-level troubleshooting and detailed optimization scenarios, Atomic Insights for Precision Labeling provides evidence-backed recommendations that extend the strategies presented here.

    Future Outlook: Next-Generation Imaging and Therapeutic Innovation

    The integration of Cy3 NHS ester (non-sulfonated) with modular, targeted platforms such as NanoTACOrg is transforming the landscape of biomedical imaging and targeted organelle degradation. As shown in the ACS Nano reference (Li et al.), fluorescently labeled biomolecules are central to tracking subcellular trafficking, autophagosomal engagement, and metabolic flux in live-cell systems. The broad spectral coverage of the cyanine dye family, combined with Cy3’s robust photostability and sensitivity, positions it as a linchpin for both fundamental research and translational applications.

    Looking forward, we anticipate further integration of Cy3 NHS ester labels in multiplexed super-resolution microscopy, quantitative proteomics, and dynamic live-cell imaging—enabling unprecedented insight into cellular machinery and disease progression. As researchers adopt more complex organelle-targeting and degradation strategies, the demand for reliable, sensitive, and customizable labeling reagents will continue to rise.

    For more on strategic integration and future-facing perspectives, Illuminating Organelle Dynamics complements the workflow- and protocol-centric focus of this article by contextualizing Cy3 NHS ester within the evolving landscape of autophagy-based technologies.

    Conclusion

    Cy3 NHS ester (non-sulfonated) from APExBIO stands at the forefront of biomedical imaging fluorescent dye innovation, empowering researchers to achieve reproducible, high-sensitivity labeling in protein, peptide, and oligonucleotide workflows. Its combination of robust photophysical properties, workflow flexibility, and compatibility with advanced organelle-targeting strategies makes it a benchmark tool for fluorescence microscopy, imaging, and targeted degradation studies. By adhering to best practices in protocol setup, troubleshooting, and data-driven optimization, researchers can fully realize the transformative potential of this dye in both foundational and translational research domains.